"Insitro's AI Biotech Breakthroughs at JPM 2024"

Insitro, a well-funded AI biotech company founded by Daphne Koller, has unveiled its efforts in ALS, liver disease, and cancer at JPM. The South San Francisco firm, which has raised over $643 million in venture capital, is making strides in the biotech industry with its AI technologies and has more than 260 employees working on its projects.